In the evolving landscape of pediatric critical care, biomarkers play a pivotal role in guiding clinicians through the complexities of sepsis—a condition notorious for its rapid progression and high mortality. Historically, serum lactate has been a cornerstone in assessing illness severity due to its reflection of tissue hypoperfusion and metabolic distress. However, lactate’s utility is compromised by its intrinsic developmental variability in children and its lack of specificity, often rising transiently in response to non-pathological stress. This has prompted investigative efforts to identify composite biomarkers that can encapsulate the multifaceted pathophysiology of sepsis, leading to the recent proposition of the lactate-to-creatinine ratio (LCR) as a superior prognostic tool.
The lactate-to-creatinine ratio amalgamates two biochemical parameters reflective of distinct but interrelated physiological domains—metabolic derangement and organ function. Lactate, a byproduct of anaerobic metabolism, serves as an indicator of cellular hypoxia and overall metabolic distress. Creatinine, conversely, is a marker indicative of renal function and early organ impairment. By integrating these markers, LCR theoretically offers a more nuanced snapshot of a child’s critical illness trajectory, encompassing both systemic metabolic insult and emerging organ dysfunction. This composite index is particularly attractive because it relies on assays routinely available in intensive care units, thereby facilitating its potential incorporation into clinical workflows without additional resource burdens.
Despite the intuitive appeal of LCR, evidence supporting its clinical utility in pediatric sepsis remains preliminary. Most studies to date have focused exclusively on static, single time-point measurements, primarily obtained upon admission to the intensive care unit. Such cross-sectional snapshots fail to capture the dynamic and rapidly evolving nature of sepsis, where metabolic and organ function statuses can fluctuate significantly within hours. This creates a critical knowledge gap: does LCR provide meaningful prognostic information beyond that offered by standard clinical evaluation and existing biomarkers when monitored longitudinally?
The current discourse challenges the dogma of relying heavily on single-point biomarker assessments for clinical decision-making in pediatric sepsis. Sepsis, by its very definition, is a complex and evolving syndrome characterized by waves of systemic inflammation, immune dysregulation, metabolic shifts, and multi-organ involvement. Given this fluidity, a biomarker that can be serially measured and interpreted within the context of clinical changes is potentially far more valuable than a solitary baseline value. The LCR, to justify clinical adoption, must demonstrate a capacity to track these physiological shifts accurately and predict critical therapeutic thresholds where intervention may positively alter outcomes.
Critically, the pathobiology underpinning LCR’s rationale rests heavily on the recognition that renal impairment is a common early complication of sepsis and a potent driver of mortality. Creatinine levels reflect glomerular filtration rate and can signal incipient kidney injury before overt clinical dysfunction becomes apparent. Concurrently, elevated lactate signals inadequate tissue perfusion and systemic metabolic stress. The conjoint consideration of these markers integrates two dimensions of sepsis pathophysiology, potentially enabling clinicians to identify patients at heightened risk of deterioration earlier than with either marker alone.
Yet, one must address the inherent limitations of creatinine as a biomarker in pediatric populations. Creatinine generation varies with age, muscle mass, and nutritional status, factors that are markedly heterogeneous in critically ill children. Furthermore, creatinine clearance, as an estimate of renal function, can lag behind actual renal tubular injury. These nuances necessitate careful calibration and interpretation of LCR values against pediatric-specific normative data, which are currently insufficiently defined. Without this context, the risk of misclassification and consequent clinical misjudgment remains substantial.
The commentary by Ingle and Kandil articulates a prudent perspective, emphasizing that the ultimate value of the LCR biomarker lies not merely in its prognostic associations but in its ability to influence clinical decision-making. Whether LCR can catalyze timely interventions—such as optimization of fluid resuscitation, renal protective strategies, or escalation of supportive therapies—remains an open question. Biomarkers that fail to offer actionable insights risk becoming academic curiosities rather than practical tools within the pediatric intensive care armamentarium.
Moreover, the scalability and accessibility of LCR measurement are not without challenges. While lactate and creatinine assays are standard in many centers, the heterogeneity in laboratory platforms and clinical protocols can influence test turnaround times and result interpretation. Integrating LCR into sepsis management algorithms therefore necessitates validation across diverse healthcare settings, with attention to operational feasibility and cost-effectiveness—especially critical in resource-limited environments where pediatric sepsis burden is often greatest.
Future research must adopt a longitudinal design, capturing serial LCR measurements across the sepsis continuum and correlating them with detailed clinical outcomes. Such studies should explore whether trends in LCR better stratify risk than isolated values and if these trends align with responses to therapeutic interventions. Additionally, synergistic evaluation with other emerging biomarkers and clinical scoring systems will be vital to contextualize LCR within a multidimensional framework of pediatric sepsis assessment.
Another important consideration involves dissecting how developmental physiology affects the relationship between lactate, creatinine, and sepsis severity. Neonates and young infants exhibit distinct metabolic and renal profiles compared to older children, potentially modulating the interpretability of LCR. Age-specific reference ranges and adjustment algorithms may be necessary to tailor LCR’s applicability across diverse pediatric subpopulations, preventing inappropriate generalization from adult-centric models.
Ingle and Kandil also caution against overreliance on biochemical markers at the expense of comprehensive clinical evaluation. Biomarkers should complement, not supplant, nuanced bedside assessment and clinical gestalt. Overinterpretation of LCR without clinical correlation may lead to unnecessary interventions or overlook complex patient-specific factors guiding care. The balance between biomarker-driven algorithms and individualized patient care remains a pivotal challenge in pediatric critical care.
The conceptual introduction of the lactate-to-creatinine ratio reflects an ongoing quest to refine risk stratification in pediatric sepsis, an area where precision diagnostics are urgently needed. By bridging metabolic and organ dysfunction domains, LCR embodies an integrative approach that aligns with the multifactorial nature of sepsis. Yet, translating this potential into meaningful clinical impact requires robust evidence, critical appraisal, and mindful implementation aligned with patient-centered goals.
In conclusion, while the lactate-to-creatinine ratio represents an intriguing addition to the biomarker landscape in pediatric sepsis, its current utility is limited by a reliance on early, single time-point measurements and insufficient validation of its dynamic behavior and clinical responsiveness. The true value of LCR will emerge only if it demonstrably enhances clinical decision-making, guides timely therapeutic actions, and ultimately improves patient outcomes. Until such data are available, caution and rigorous scientific scrutiny remain paramount.
The journey to optimize pediatric sepsis biomarkers continues, with LCR standing as a promising but as yet unproven candidate. The critical care community awaits prospective, methodologically sound investigations that can delineate its role amid a growing array of diagnostic tools. This endeavor is not merely academic but essential, as improving prognostication and personalized management in pediatric sepsis holds the promise of saving lives and mitigating long-term morbidity.
As the medical field progresses toward precision medicine, composite biomarkers like LCR could herald a new era of individualized risk stratification, striking at the heart of sepsis’s heterogeneity. The integration of metabolic and organ function assessments paves the way for more refined prognostic models, yet their success hinges on collaborative efforts across disciplines to ensure reliability, interpretability, and relevance at the bedside.
In the meantime, continuing reliance on established clinical parameters and vigilant bedside assessment, supplemented judiciously by evolving biomarkers such as LCR, offers the best approach to managing the dynamic and complex syndrome of pediatric sepsis. Understanding such biomarkers’ mechanistic underpinnings enhances clinicians’ insight, even as the quest for actionable innovations perseveres.
Subject of Research: Pediatric sepsis biomarkers, metabolic derangement, organ dysfunction, lactate-to-creatinine ratio (LCR)
Article Title: Lactate to creatinine ratio: just another biomarker?
Article References:
Ingle, T., Kandil, S.B. Lactate to creatinine ratio: just another biomarker?. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04985-7
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41390-026-04985-7
Tags: composite biomarkers for sepsiscritical care biomarkers in pediatricsearly detection of organ impairmentlactate variability in pediatric patientslactate-to-creatinine ratio biomarkermetabolic and renal biomarker integrationmetabolic distress indicators in childrenorgan dysfunction biomarkerspediatric critical illness assessmentpediatric sepsis prognosisrenal function markers in sepsissepsis severity assessment tools
